CRISPR-Cas9 is a method for quickly and accurately editing the genome of virtually any living thing. Using custom-built guide RNA paired with a cutting enzyme (Cas9), it can find and snip a selected sequence of DNA or RNA, eliminating or replacing a “bad” gene. Since it was first described, in late 2012, CRISPR has drastically accelerated the scope of research and moved into practical applications in medicine. So far in 2020, there are 15 trials underway. In medicine, where new drugs take a decade or more to develop, that’s game changing.
Infographic: What CRISPR is curing in 2020
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.
Outbreak Daily Digest
The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
- A cure for COVID? Scientists now think it’s possible, and it may come soon
- How Freddie Mercury got his voice: It wasn’t his teeth
- Video: 10 of the most prominent anti-vaccine celebrities, from Jim Carrey to Jenny McCarthy
- Homo sapiens reevaluated: Why the definition of ‘modern human’ is undergoing a revamp
- Altruism in animals: Why do animals sometimes adopt other species’ unrelated orphans?
- 9 archaeological finds that have reshaped our views of human evolution
- Which provides better long-term protection against coronavirus reinfection: An actual infection or a vaccine?
- ‘This was the first time nobody voted for approval of a drug’: Neurologist on FDA panel that negatively evaluated controversial Alzheimer’s drug aducanumab resigns after agency pushes through approval
- ‘They can put a key on their forehead. It sticks’: Ohio GOP embraces crackpot doctor’s view that COVID vaccines leave people and interfaces with 5G towers
- Facing mounting number of glyphosate lawsuits, Bayer offers 5-point plan to address future Roundup weedkiller claims